{"id":"https://openalex.org/W1973757121","doi":"https://doi.org/10.1089/jop.2009.0120","title":"A Novel Nitric Oxide Releasing Prostaglandin Analog, NCX 125, Reduces Intraocular Pressure in Rabbit, Dog, and Primate Models of Glaucoma","display_name":"A Novel Nitric Oxide Releasing Prostaglandin Analog, NCX 125, Reduces Intraocular Pressure in Rabbit, Dog, and Primate Models of Glaucoma","publication_year":2010,"publication_date":"2010-04-01","ids":{"openalex":"https://openalex.org/W1973757121","doi":"https://doi.org/10.1089/jop.2009.0120","mag":"1973757121","pmid":"https://pubmed.ncbi.nlm.nih.gov/20415621"},"language":"en","primary_location":{"id":"doi:10.1089/jop.2009.0120","doi":"https://doi.org/10.1089/jop.2009.0120","is_oa":false,"landing_page_url":"https://doi.org/10.1089/jop.2009.0120","pdf_url":null,"source":{"id":"https://openalex.org/S192126995","display_name":"Journal of Ocular Pharmacology and Therapeutics","issn_l":"1080-7683","issn":["1080-7683","1557-7732","8756-3320"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Ocular Pharmacology and Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5105232866","display_name":"Valentina Borghi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Valentina Borghi","raw_affiliation_strings":["NicOx Research Institute, Bresso, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NicOx Research Institute, Bresso, Milan, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042140947","display_name":"Elena Bastia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elena Bastia","raw_affiliation_strings":["NicOx Research Institute, Bresso, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NicOx Research Institute, Bresso, Milan, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037481083","display_name":"Massimiliano Guzzetta","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Massimiliano Guzzetta","raw_affiliation_strings":["NicOx Research Institute, Bresso, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NicOx Research Institute, Bresso, Milan, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090452749","display_name":"Valerio Chiroli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Valerio Chiroli","raw_affiliation_strings":["NicOx Research Institute, Bresso, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NicOx Research Institute, Bresso, Milan, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091104086","display_name":"Carol B. Toris","orcid":"https://orcid.org/0000-0003-3794-6142","observed_orcids":["https://orcid.org/0000-0003-3794-6142"]},"institutions":[{"id":"https://openalex.org/I122266389","display_name":"University of Nebraska at Omaha","ror":"https://ror.org/04yrkc140","country_code":"US","type":"education","lineage":["https://openalex.org/I122266389"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carol B. Toris","raw_affiliation_strings":["University of Nebraska, Omaha, Nebraska","Ophthalmology and Visual Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Nebraska, Omaha, Nebraska","institution_ids":["https://openalex.org/I122266389"]},{"raw_affiliation_string":"Ophthalmology and Visual Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069555356","display_name":"Minerva R. Batugo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Minerva R. Batugo","raw_affiliation_strings":["Pfizer Global Research and Development-La Jolla, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global Research and Development-La Jolla, San Diego, California","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080776915","display_name":"Samantha T. Carreiro","orcid":"https://orcid.org/0009-0000-8287-4956","observed_orcids":["https://orcid.org/0009-0000-8287-4956"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samantha T. Carreiro","raw_affiliation_strings":["Pfizer Global Research and Development-La Jolla, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global Research and Development-La Jolla, San Diego, California","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040207336","display_name":"Wesley K. M. Chong","orcid":"https://orcid.org/0000-0002-2063-0697","observed_orcids":["https://orcid.org/0000-0002-2063-0697"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wesley K.M. Chong","raw_affiliation_strings":["Pfizer Global Research and Development-La Jolla, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global Research and Development-La Jolla, San Diego, California","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054982559","display_name":"David C. Gale","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David C. Gale","raw_affiliation_strings":["Pfizer Global Research and Development-La Jolla, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global Research and Development-La Jolla, San Diego, California","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061897311","display_name":"David J. Kucera","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David J. Kucera","raw_affiliation_strings":["Pfizer Global Research and Development-La Jolla, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global Research and Development-La Jolla, San Diego, California","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100707065","display_name":"Jia Liu","orcid":"https://orcid.org/0000-0001-6274-2710","observed_orcids":["https://orcid.org/0000-0001-6274-2710"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Liu Jia","raw_affiliation_strings":["Pfizer Global Research and Development-La Jolla, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global Research and Development-La Jolla, San Diego, California","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091860060","display_name":"Ganesh Prasanna","orcid":"https://orcid.org/0000-0001-6420-270X","observed_orcids":["https://orcid.org/0000-0001-6420-270X"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ganesh Prasanna","raw_affiliation_strings":["Pfizer Global Research and Development-La Jolla, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global Research and Development-La Jolla, San Diego, California","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113533558","display_name":"Ennio Ongini","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ennio Ongini","raw_affiliation_strings":["NicOx Research Institute, Bresso, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NicOx Research Institute, Bresso, Milan, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061951892","display_name":"Achim H.\u2010P. Krauss","orcid":"https://orcid.org/0000-0002-9347-8745","observed_orcids":["https://orcid.org/0000-0002-9347-8745"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Achim H.P. Krauss","raw_affiliation_strings":["Pfizer Global Research and Development-La Jolla, San Diego, California","GlaxoSmithKline"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global Research and Development-La Jolla, San Diego, California","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"GlaxoSmithKline","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077892371","display_name":"Francesco Impagnatiello","orcid":"https://orcid.org/0000-0003-2220-113X","observed_orcids":["https://orcid.org/0000-0003-2220-113X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francesco Impagnatiello","raw_affiliation_strings":["NicOx Research Institute, Bresso, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NicOx Research Institute, Bresso, Milan, Italy","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.0479,"has_fulltext":false,"cited_by_count":68,"citation_normalized_percentile":{"value":0.94617465,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"26","issue":"2","first_page":"125","last_page":"132"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nitric-oxide-donors","display_name":"nitric oxide donors","score":0.8209999799728394},{"id":"https://openalex.org/keywords/prostaglandin-analogs","display_name":"prostaglandin analogues","score":0.8730000257492065},{"id":"https://openalex.org/keywords/latanoprost","display_name":"latanoprost","score":0.9779999852180481},{"id":"https://openalex.org/keywords/intraocular-pressure","display_name":"intraocular pressure","score":0.8309999704360962},{"id":"https://openalex.org/keywords/glaucoma","display_name":"glaucoma","score":0.9240000247955322},{"id":"https://openalex.org/keywords/ocular-hypotensive-agents","display_name":"ocular hypotensive agents","score":0.9129999876022339},{"id":"https://openalex.org/keywords/cgmp-signaling","display_name":"cGMP signaling","score":0.6349999904632568},{"id":"https://openalex.org/keywords/inos-inhibition","display_name":"iNOS inhibition","score":0.9120000004768372},{"id":"https://openalex.org/keywords/aqueous-humor-dynamics","display_name":"aqueous humor dynamics","score":0.718999981880188},{"id":"https://openalex.org/keywords/ocular-hypertension","display_name":"ocular hypertension","score":0.7549999952316284},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7379999756813049},{"id":"https://openalex.org/keywords/nonhuman-primates","display_name":"non-human primates","score":0.7129999995231628},{"id":"https://openalex.org/keywords/dogs","display_name":"dogs","score":0.6629999876022339},{"id":"https://openalex.org/keywords/rabbits","display_name":"rabbits","score":0.7599999904632568},{"id":"https://openalex.org/keywords/pc12-cells","display_name":"PC12 cells","score":0.7200000286102295},{"id":"https://openalex.org/keywords/raw-264-7-macrophages","display_name":"RAW 264.7 macrophages","score":0.9950000047683716}],"concepts":[{"id":"https://openalex.org/C2781092963","wikidata":"https://www.wikidata.org/wiki/Q650050","display_name":"Intraocular pressure","level":2,"score":0.7539063692092896},{"id":"https://openalex.org/C2778527774","wikidata":"https://www.wikidata.org/wiki/Q159701","display_name":"Glaucoma","level":2,"score":0.7494511008262634},{"id":"https://openalex.org/C2779526769","wikidata":"https://www.wikidata.org/wiki/Q4859319","display_name":"Prostaglandin analogue","level":3,"score":0.6980687975883484},{"id":"https://openalex.org/C519581460","wikidata":"https://www.wikidata.org/wiki/Q207843","display_name":"Nitric oxide","level":2,"score":0.6969202756881714},{"id":"https://openalex.org/C2780664492","wikidata":"https://www.wikidata.org/wiki/Q209717","display_name":"Prostaglandin","level":2,"score":0.5184532999992371},{"id":"https://openalex.org/C2780509455","wikidata":"https://www.wikidata.org/wiki/Q7380","display_name":"Primate","level":2,"score":0.5065263509750366},{"id":"https://openalex.org/C2779884254","wikidata":"https://www.wikidata.org/wiki/Q492162","display_name":"Rabbit (cipher)","level":2,"score":0.48813971877098083},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4624026417732239},{"id":"https://openalex.org/C2779133491","wikidata":"https://www.wikidata.org/wiki/Q25401","display_name":"Lagomorpha","level":2,"score":0.4489808976650238},{"id":"https://openalex.org/C2910015228","wikidata":"https://www.wikidata.org/wiki/Q9294051","display_name":"Elevated intraocular pressure","level":3,"score":0.42594286799430847},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.3924955725669861},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.36536091566085815},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.35310184955596924},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3511735200881958},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.32677119970321655},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2166961431503296},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.12637430429458618},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001082","descriptor_name":"Aqueous Humor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002924","descriptor_name":"Ciliary Body","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005901","descriptor_name":"Glaucoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005901","descriptor_name":"Glaucoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006152","descriptor_name":"Cyclic GMP","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007429","descriptor_name":"Intraocular Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D007498","descriptor_name":"Iris","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008252","descriptor_name":"Macaca fascicularis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008264","descriptor_name":"Macrophages","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008264","descriptor_name":"Macrophages","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009569","descriptor_name":"Nitric Oxide","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D009798","descriptor_name":"Ocular Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009798","descriptor_name":"Ocular Hypertension","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009883","descriptor_name":"Ophthalmic Solutions","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011461","descriptor_name":"Prostaglandins F, Synthetic","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D011461","descriptor_name":"Prostaglandins F, Synthetic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011465","descriptor_name":"Prostaglandins, Synthetic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D052247","descriptor_name":"Nitric Oxide Synthase Type II","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1089/jop.2009.0120","doi":"https://doi.org/10.1089/jop.2009.0120","is_oa":false,"landing_page_url":"https://doi.org/10.1089/jop.2009.0120","pdf_url":null,"source":{"id":"https://openalex.org/S192126995","display_name":"Journal of Ocular Pharmacology and Therapeutics","issn_l":"1080-7683","issn":["1080-7683","1557-7732","8756-3320"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Ocular Pharmacology and Therapeutics","raw_type":"journal-article"},{"id":"pmid:20415621","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20415621","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W7267938","https://openalex.org/W168887062","https://openalex.org/W1490514271","https://openalex.org/W1585390129","https://openalex.org/W1967805987","https://openalex.org/W1974896557","https://openalex.org/W1978869728","https://openalex.org/W1983742520","https://openalex.org/W1997757103","https://openalex.org/W2010755453","https://openalex.org/W2010975636","https://openalex.org/W2014148245","https://openalex.org/W2036329737","https://openalex.org/W2037011595","https://openalex.org/W2039115427","https://openalex.org/W2048686092","https://openalex.org/W2065579376","https://openalex.org/W2069881405","https://openalex.org/W2070713040","https://openalex.org/W2072365851","https://openalex.org/W2088729055","https://openalex.org/W2092033036","https://openalex.org/W2096078834","https://openalex.org/W2122477596","https://openalex.org/W2136654293","https://openalex.org/W4255191103"],"related_works":["https://openalex.org/W2083486276","https://openalex.org/W2138746276","https://openalex.org/W2742184924","https://openalex.org/W2800772078","https://openalex.org/W3133807867","https://openalex.org/W4237488811","https://openalex.org/W2022189687","https://openalex.org/W4392881665","https://openalex.org/W2948063891","https://openalex.org/W2084248258"],"abstract_inverted_index":{"PURPOSE:":[0],"Nitric":[1],"oxide":[2],"(NO)":[3],"is":[4,235],"involved":[5],"in":[6,50,72,95,111,216,221,249],"a":[7,31,120,229],"variety":[8],"of":[9,25,79,131,252,256],"physiological":[10],"processes":[11],"including":[12],"ocular":[13,133,152,181,224,239],"aqueous":[14],"humor":[15],"dynamics":[16],"by":[17],"targeting":[18,231],"mechanisms":[19],"that":[20],"are":[21],"complementary":[22],"to":[23,55,119,245],"those":[24],"prostaglandins.":[26],"Here,":[27],"we":[28],"have":[29],"characterized":[30],"newly":[32],"synthesized":[33,47],"compound,":[34],"NCX":[35,44,82,115,140,167,197,211,227],"125,":[36,141,168,198,228],"comprising":[37],"latanoprost":[38,65,126,214],"acid":[39,219],"and":[40,48,60,75,98,178,213],"NO-donating":[41],"moieties.":[42],"METHODS:":[43],"125":[45,83,116,212],"was":[46],"tested":[49],"vitro":[51],"for":[52,66],"its":[53,67],"ability":[54],"release":[56],"functionally":[57],"active":[58],"NO":[59],"then":[61],"compared":[62,123],"with":[63,124,237],"core":[64],"intraocular":[68],"pressure":[69],"(IOP)-lowering":[70],"effects":[71],"rabbit,":[73],"dog,":[74],"nonhuman":[76],"primate":[77],"models":[78],"glaucoma.":[80,257],"RESULTS:":[81],"elicited":[84],"cGMP":[85],"formation":[86],"(EC(50)":[87],"=":[88,104,143,170,188,200],"3.8":[89],"+":[90,106,145,160,172,190,202],"or":[91,107,146,161,173,191,203],"-":[92,108,147,162,174,192,204],"1.0":[93],"microM)":[94,110],"PC12":[96],"cells":[97],"exerted":[99],"NO-dependent":[100],"iNOS":[101],"inhibition":[102],"(IC(50)":[103],"55":[105],"11":[109],"RAW":[112],"264.7":[113],"macrophages.":[114],"lowered":[117],"IOP":[118],"greater":[121],"extent":[122],"equimolar":[125],"in:":[127],"(a)":[128],"rabbit":[129],"model":[130],"transient":[132],"hypertension":[134],"(0.030%":[135,156],"latanoprost,":[136,157,186],"not":[137],"effective;":[138],"0.039%":[139,166],"Delta(max)":[142,169,187,199],"-10.6":[144],"2.3":[148],"mm":[149,164,176,194,206],"Hg),":[150,177],"(b)":[151],"hypertensive":[153,182],"glaucomatous":[154],"dogs":[155],"Delta(max)=":[158],"-6.7":[159],"1.2":[163],"Hg;":[165],"-9.1":[171],"3.1":[175],"(c)":[179],"laser-induced":[180],"non-human":[183],"primates":[184],"(0.10%":[185],"-11.9":[189],"3.7":[193],"Hg,":[195],"0.13%":[196],"-16.7":[201],"2.2":[205],"Hg).":[207],"In":[208],"pharmacokinetic":[209],"studies,":[210],"resulted":[215],"similar":[217],"latanoprost-free":[218],"exposure":[220],"anterior":[222],"segment":[223],"tissues.":[225],"CONCLUSIONS:":[226],"compound":[230],"2":[232],"different":[233],"mechanisms,":[234],"endowed":[236],"potent":[238],"hypotensive":[240],"effects.":[241],"This":[242],"may":[243],"lead":[244],"potential":[246],"new":[247],"perspectives":[248],"the":[250],"treatment":[251],"patients":[253],"at":[254],"risk":[255]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}